These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37765214)

  • 1. The Path from Nasal Tissue to Nasal Mucosa on Chip: Part 1-Establishing a Nasal In Vitro Model for Drug Delivery Testing Based on a Novel Cell Line.
    Bendas S; Koch EV; Nehlsen K; May T; Dietzel A; Reichl S
    Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs.
    Gonçalves VSS; Matias AA; Poejo J; Serra AT; Duarte CMM
    Int J Pharm; 2016 Dec; 515(1-2):1-10. PubMed ID: 27702697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Path from Nasal Tissue to Nasal Mucosa on Chip: Part 2-Advanced Microfluidic Nasal In Vitro Model for Drug Absorption Testing.
    Koch EV; Bendas S; Nehlsen K; May T; Reichl S; Dietzel A
    Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved In Vitro Model for Intranasal Mucosal Drug Delivery: Primary Olfactory and Respiratory Epithelial Cells Compared with the Permanent Nasal Cell Line RPMI 2650.
    Ladel S; Schlossbauer P; Flamm J; Luksch H; Mizaikoff B; Schindowski K
    Pharmaceutics; 2019 Aug; 11(8):. PubMed ID: 31374872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RPMI 2650 epithelial model and three-dimensional reconstructed human nasal mucosa as in vitro models for nasal permeation studies.
    Wengst A; Reichl S
    Eur J Pharm Biopharm; 2010 Feb; 74(2):290-7. PubMed ID: 19733661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of RPMI 2650 cell layers and excised sheep nasal epithelial tissues in terms of nasal drug delivery and immunocytochemistry properties.
    Gerber W; Svitina H; Steyn D; Peterson B; Kotzé A; Weldon C; Hamman JH
    J Pharmacol Toxicol Methods; 2022; 113():107131. PubMed ID: 34699972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of RPMI 2650 nasal cell model to a 3D printed apparatus for the testing of drug deposition and permeation of nasal products.
    Pozzoli M; Ong HX; Morgan L; Sukkar M; Traini D; Young PM; Sonvico F
    Eur J Pharm Biopharm; 2016 Oct; 107():223-33. PubMed ID: 27418393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cultivation of RPMI 2650 cells as an in-vitro model for human transmucosal nasal drug absorption studies: optimization of selected culture conditions.
    Reichl S; Becker K
    J Pharm Pharmacol; 2012 Nov; 64(11):1621-30. PubMed ID: 23058049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-time quantitative monitoring of
    Gholizadeh H; Ong HX; Bradbury P; Kourmatzis A; Traini D; Young P; Li M; Cheng S
    Expert Opin Drug Deliv; 2021 Jun; 18(6):803-818. PubMed ID: 33410717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suitability of RPMI 2650 cell models for nasal drug permeability prediction.
    Sibinovska N; Žakelj S; Kristan K
    Eur J Pharm Biopharm; 2019 Dec; 145():85-95. PubMed ID: 31639418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The characterization of the human nasal epithelial cell line RPMI 2650 under different culture conditions and their optimization for an appropriate in vitro nasal model.
    Kreft ME; Jerman UD; Lasič E; Lanišnik Rižner T; Hevir-Kene N; Peternel L; Kristan K
    Pharm Res; 2015 Feb; 32(2):665-79. PubMed ID: 25145337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid and hydrocortisone strengthen the barrier function of human RPMI 2650 cells, a model for nasal epithelial permeability.
    Kürti L; Veszelka S; Bocsik A; Ozsvári B; Puskás LG; Kittel A; Szabó-Révész P; Deli MA
    Cytotechnology; 2013 May; 65(3):395-406. PubMed ID: 22940916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and application of an ex vivo fosphenytoin nasal bioconversion/permeability evaluation method.
    Antunes Viegas D; Rodrigues M; Francisco J; Falcão A; Alves G; Santos AO
    Eur J Pharm Sci; 2016 Jun; 89():61-72. PubMed ID: 27106504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of the 3D MucilAir™ nasal model.
    Mercier C; Jacqueroux E; He Z; Hodin S; Constant S; Perek N; Boudard D; Delavenne X
    Eur J Pharm Biopharm; 2019 Jun; 139():186-196. PubMed ID: 30951820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different Culture Conditions Affect Drug Transporter Gene Expression, Ultrastructure, and Permeability of Primary Human Nasal Epithelial Cells.
    Kreft ME; Tratnjek L; Lasič E; Hevir N; Rižner TL; Kristan K
    Pharm Res; 2020 Aug; 37(9):170. PubMed ID: 32820417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of critical parameters using an air-liquid interface model with RPMI 2650 cells for permeability studies of small molecules.
    Barlang LA; Weinbender K; Merkel OM; Popp A
    Drug Deliv Transl Res; 2024 Jun; 14(6):1601-1615. PubMed ID: 37978162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling the bronchial barrier in pulmonary drug delivery: A human bronchial epithelial cell line supplemented with human tracheal mucus.
    Murgia X; Yasar H; Carvalho-Wodarz C; Loretz B; Gordon S; Schwarzkopf K; Schaefer U; Lehr CM
    Eur J Pharm Biopharm; 2017 Sep; 118():79-88. PubMed ID: 28373109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro cell culture models of the nasal epithelium: a comparative histochemical investigation of their suitability for drug transport studies.
    Werner U; Kissel T
    Pharm Res; 1996 Jul; 13(7):978-88. PubMed ID: 8842033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of P-glycoprotein in excised human nasal mucosa and optimized models of RPMI 2650 cells.
    Dolberg AM; Reichl S
    Int J Pharm; 2016 Jul; 508(1-2):22-33. PubMed ID: 27155589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies.
    Eigenmann DE; Xue G; Kim KS; Moses AV; Hamburger M; Oufir M
    Fluids Barriers CNS; 2013 Nov; 10(1):33. PubMed ID: 24262108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.